Enoxacin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Substance from the group of gyrase inhibitors.

Half-lifeThis section has been translated automatically.

4–6 h

IndicationThis section has been translated automatically.

Infections of the urinary tract, kidney, prostate; respiratory tract, ear, nose and throat, skin and skin appendages.

Dosage and method of useThis section has been translated automatically.

  • 400-800 mg/day p.o. over max. 14 days.
  • Gonorrhoea: 400 mg p.o. as ED.
  • Ulcus molle: 3 times 400 mg p.o. at intervals of 12 hours.

Undesirable effectsThis section has been translated automatically.

S.u. Ciprofloxacin. Additional photosensitivity.

PreparationsThis section has been translated automatically.

Enoxor

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer